Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ImmuCell | ICCC | Mar 14, 2025 | 4.99 | +2.05 |
Immuneering A | IMRX | Mar 14, 2025 | 1.60 | +3.90 |
Immunic | IMUX | Mar 14, 2025 | 1.15 | +2.68 |
ImmunityBio | IBRX | Mar 14, 2025 | 2.87 | -1.03 |
Immunocore ADR | IMCR | Mar 14, 2025 | 28.80 | +1.87 |
Immunome | IMNM | Mar 14, 2025 | 8.77 | -1.79 |
ImmunoPrecise Antibodies | IPA | Mar 14, 2025 | 0.38 | -4.96 |
Immunovant | IMVT | Mar 14, 2025 | 19.52 | +3.89 |
Immutep ADR | IMMP | Mar 14, 2025 | 1.78 | +1.71 |
Imperial Oil | IMO | Mar 14, 2025 | 67.90 | +1.92 |
Imperial Petroleum | IMPP | Mar 14, 2025 | 2.46 | +2.50 |
Imperial Petroleum A Pref | IMPPP | Mar 14, 2025 | 24.70 | 0.00 |
Impinj | PI | Mar 14, 2025 | 90.34 | +1.03 |
Imunon | IMNN | Mar 14, 2025 | 0.87 | -1.42 |
IN8bio | INAB | Mar 14, 2025 | 0.23 | -0.40 |
Inari Medical | NARI | Mar 14, 2025 | 79.97 | 0.00 |
Incannex Healthcare ADR | IXHL | Mar 14, 2025 | 0.74 | -1.33 |
Income Opportunity Realty Investors | IOR | Mar 14, 2025 | 17.75 | 0.00 |
Incyte | INCY | Mar 14, 2025 | 67.86 | +0.22 |
Indaptus Therapeutics | INDP | Mar 14, 2025 | 0.81 | -0.21 |
Independence Realty Trust | IRT | Mar 14, 2025 | 20.98 | +1.99 |
Independent Bank | INDB | Mar 14, 2025 | 63.66 | +3.73 |
Independent Bank | IBCP | Mar 14, 2025 | 30.91 | +2.35 |
India Bull 3X Direxion | INDL | Mar 14, 2025 | 50.44 | +1.53 |
India Consumer Egshares | INCO | Mar 14, 2025 | 57.08 | +0.88 |
India Earnings Wisdomtree | EPI | Mar 14, 2025 | 41.43 | +0.85 |
India Fund | IFN | Mar 14, 2025 | 14.88 | +0.95 |
India Powershares | PIN | Mar 14, 2025 | 23.82 | +0.86 |
Indie Semiconductor A | INDI | Mar 14, 2025 | 2.34 | -2.09 |
Indivior | INDV | Mar 14, 2025 | 9.68 | +0.94 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.